Alpine Associates Management’s Verona Pharma VRNA Stock Holding History

Alpine Associates Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,157,050	Closed	-$123M	–	100
2025 Q3	$123M	Buy	+1,157,050	New	+$121M	7.45%	2

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Alpine Associates Management's VRNA Position: Q4 2025 in Review

Alpine Associates Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,157,050 shares — an estimated $123M sold.

Alpine Associates Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $123M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Alpine Associates Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Alpine Associates Management sold 1,157,050 Verona Pharma shares in Q4 2025, an estimated $123M.
Alpine Associates Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Alpine Associates Management's Verona Pharma position peaked at $123M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Alpine Associates Management's 13F filing for Q4 2025, filed 5 Feb 2026.